Harsh Maggon
Partner - Corporate
Mergers and Acquisitions (Public & Private) | Private Equity
Overview
Harsh Maggon is part of the Corporate practice group specialising in public mergers & acquisitions and private equity transactions. He specialises in public and private M&A and private equity transactions. He has advised on some of the largest control deals in India, including multiple takeover offers, schemes of arrangement and delisting offers. In addition, Harsh has advised boards of directors and senior management of Indian listed companies on complex governance issues and assisted in developing strategies to deal with potential minority shareholder claims and regulatory action. He has extensive experience in advising private equity funds and foreign strategic investors on complex deals, regulatory issues and concerns that typically arise in Indian deals when negotiating with Indian promoters/sellers.
Harsh also focuses on the firm’s Healthcare and Lifesciences practice and has extensive experience in this space. He routinely advises some of the largest hospital and pharma companies, including the Manipal group, J.B. Chemicals and Piramal Pharma.
Education
B.S.L.LLB, Symbiosis International University, Pune
Admissions
Bar Council of Maharashtra and Goa
Select representative clients/matters
Harsh has advised the following clients during the course of his career:
- Zee Group, on the merger of Zee Entertainment Ltd with Sony India to create a merged company valued at approximately USD 10 billion
- Future Group, on sale of their retail and wholesale trading business to Reliance Group for approximately USD 3.4 billion
- Piramal, on sale of Piramal Glass to Blackstone for approximately USD 1 billion
- Brookfield Private Equity, on its proposed acquisition of a significant stake in the plastics films business of Jindal Polyfilms Ltd for approximately USD 300 million
- Manipal Group, on the acquisition of Vikram Hospitals Pvt Ltd (approximately USD 50 million), fundraising from National Infrastructure and Investment Fund (approximately 300 million)
- KKR-Radiant, on their acquisition of Max Hospitals for approximately USD 1 billion
- Reliance Industries, on the acquisition of Den Networks (approximately USD 1 billion) and Alok Industries (approximately USD 800 million)
Recognition
- Up and Coming – Corporate/M&A, Chambers and Partners (Asia-Pacific), 2022-2023
- ‘Notable Practitioner’ by the IFLR1000 Guide, from 2018 to 2021
